Numerous studies have reported the aberrant expression of AGGF1 in cancer tissues and its involvement in malignant progression, such as in gastric cancer, hepatocellular carcinoma, and serous ovarian cancer [10–12]. The gene discussed is AGGF1; the disease is hepatocellular carcinoma.